PMID: 11323143Apr 27, 2001Paper

Chronic low-level administration of diquat increases the nociceptive response to gastric distension in rats: role of mast cells and tachykinin receptor activation

Pain
P M AntonL Buéno

Abstract

Dietary factors can modulate visceral sensitivity and are suggested to interact with neuroimmune pathways. To determine whether daily low-level exposure to a food contaminant (diquat) alters sensitivity to gastric distension (GD) and the role of mast cells and tachykinin receptors activation, two series of experiments were conducted in eight groups of eight male Wistar rats (200-250 g) receiving daily doses of either diquat (0.1 mg/kg per day orally) or water for 21 days. In the first series, rats were sacrificed at the end of treatments and the gastric mucosal mast cell (MMC) number was histologically quantified. In the second series, after 21 days of treatment the cardiovascular depressor (CVD) response and corresponding gastric volumes were recorded under GD (from 10 to 40 mmHg). Doxantrazole (5 mg/kg intraperitoneally (i.p.)), a mast cell stabilizer, and SR 140333 (1 mg/kg i.p.) and MEN 11420 (0.1 mg/kg intravenously), respectively NK1 and NK2 receptor antagonists, were administered before GD. Before and after GD, blood samples were taken to measure blood histamine and the gastric MMC number was determined after sacrifice. Diquat treatment increased the MMC number. In diquat-treated rats, GD increased the CVD response and b...Continue Reading

References

Sep 1, 1977·Toxicology and Applied Pharmacology·H C CrabtreeM S Rose
Nov 1, 1992·Human & Experimental Toxicology·J M RawlingsJ R Heylings
Oct 1, 1991·Gastroenterology·F MearinJ R Malagelada
Jan 1, 1990·Virchows Archiv. A, Pathological Anatomy and Histopathology·T J ChristmasR T Turner-Warwick
May 1, 1990·Pain·T J Ness, G F Gebhart
Nov 1, 1990·Digestive Diseases and Sciences·S E MatterP B Miner
Sep 1, 1988·British Journal of Pharmacology·M A LowmanM K Church
Sep 1, 1989·Gastroenterology·R H SteadJ Bienenstock
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·L R SterankaS H Snyder
Sep 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·S J Clark, T W Smith
Dec 31, 1981·Biochemical and Biophysical Research Communications·F LembeckJ Donnerer
Nov 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·F Lembeck, G Skofitsch
Nov 1, 1994·Immunology Today·D M McKay, J Bienenstock
Mar 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·S B McMahon
Jan 1, 1997·Pharmacology & Therapeutics·P Holzer, U Holzer-Petsche
Jun 18, 1997·Regulatory Peptides·C A Maggi
Feb 7, 1998·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M GuéL Buéno
Mar 4, 1998·British Journal of Pharmacology·R M CataliotoC A Maggi
Apr 29, 1998·Digestive Diseases and Sciences·A M CoelhoL Bueno
Jun 18, 1998·Annals of the New York Academy of Sciences·P A Anton, F Shanahan
Sep 30, 1998·Digestive Diseases and Sciences·M L RouzadeL Bueno
Mar 2, 1999·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P G McLeanL Buéno
Sep 1, 1999·Alimentary Pharmacology & Therapeutics·M L RouzadeL Bueno
Jan 13, 2000·Alimentary Pharmacology & Therapeutics·S Rodriguez-StanleyP B Miner
Sep 21, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Z Xiang, G Nilsson

❮ Previous
Next ❯

Citations

Aug 20, 2002·Journal of Clinical Gastroenterology·Michael J Callahan
Jan 12, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·T OshimaH Miwa
Mar 24, 2004·British Journal of Pharmacology·Alessandro LecciCarlo Alberto Maggi
Jun 5, 2003·Expert Opinion on Therapeutic Targets·Alessandro Lecci, Carlo Alberto Maggi
Mar 27, 2003·Cell and Tissue Research·Laurel M PattersonHans-Rudolf Berthoud

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.